Related ArticlesLongitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer

guest published in:05-24   reply:0   view:119    last updated:05-24 04:27( guest )

Yes another episode from the product people like to call CPM. I had a testuser with the following error after initializing the CPM Agent during logon

guest published in:04-14   reply:0   view:97    last updated:04-14 21:53( guest )

This is the fifth in a series of posts on the CDC's (Centers for Disease Control and Prevention) public use mortality data sets. In the fourth blog of this series we learned how the cause of death data from death certificate records is is transformed into a mortality record consisting of an alp ...

guest published in:12-14   reply:0   view:137    last updated:12-14 19:26( guest )

author:admin    comment:0   view:86   userful 1

New data show patients with chronic low back pain on Cymbalta(R) (duloxetine HCl) maintained reductions in pain for 41 weeks.(1) In patients who initially responded to duloxetine this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant a ...

author:admin    comment:0   view:53   userful 1

FOSTER CITY Calif.----Gilead Sciences Inc. today announced the publication of data from DAR-311 a Phase III clinical trial evaluating the company’s once-daily oral endothelin receptor antagonist darusentan as an add-on treatment for resistant hypertension defined as the failure to achieve bl ...

author:admin    comment:0   view:86   userful 1

Japan's government approved its biggest-ever budget on Wednesday to try to revive an economy hurt by the global financial crisis and U.S. data was expected to give further evidence of the worsening recession.

author:admin    comment:0   view:102   userful 1

Abraxis BioScience Inc. (NASDAQ:ABII) a fully integrated global biotechnology company today announced that multiple studies of ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) will be presented at the 31st Annual San Antonio B ...

author:admin    comment:0   view:80   userful 1

Abraxis BioScience Inc. (NASDAQ:ABII) a fully integrated global biotechnology company today announced that multiple studies of ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) will be presented at the 31st Annual San Antonio B ...